Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy

Findings from the HEP2 study imply that FTRE improves over time, ASM additions had low probability of achieving seizure freedom but contributed to seizure reduction, and device-treated participants exhibited similar seizure trajectories to those without devices. Whether improvements reflected the natural history of FTRE or active management remains unclear, but our findings suggest cautious interpretation of open-label studies positing disease-modifying effects and further research into FTRE treatment response.

Authors

Institutions

Publication Details

Journal
JAMA Neurology
Published
2025-10-20
DOI
https://doi.org/10.1001/jamaneurol.2025.4085
Citations
4
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
5.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy

Mikhail S. Gelfand, Andrés M. Kanner, Ojas Potnis, Gregory D. Cascino et al.
4 citations
JAMA Neurology
Epilepsy research and treatment
5.88
article

Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy

Mikhail S. Gelfand, Andrés M. Kanner, Ojas Potnis, Gregory D. Cascino, Kimford J. Meador, Brandy Fureman, Kamil Detyniecki, Gary Cutter, Dennis Dlugos, Hamada Hamid Altalib, Manisha Holmes, John Hixon, Jacqueline A. French, Caitlin L. Grzeskowiak, Barry E. Gidal, Paul Atkinson, Heath Pardoe, Ruben Kuzniecky, Gabriel Biondo, Rachel Sukonik, Robert T. Wechsler, Daniel H. Lowenstein, Manu Hegde, Bassel Abou-Khalil, Chris Morrison
article en
4 citations

Abstract

Findings from the HEP2 study imply that FTRE improves over time, ASM additions had low probability of achieving seizure freedom but contributed to seizure reduction, and device-treated participants exhibited similar seizure trajectories to those without devices. Whether improvements reflected the natural history of FTRE or active management remains unclear, but our findings suggest cautious interpretation of open-label studies positing disease-modifying effects and further research into FTRE treatment response.

JAMA NeurologyVol. 82(12)
University of Notre Dame (US), Northwell Health (US), University of California, San Francisco (US), Epilepsy Foundation (US), University of Alabama at Birmingham (US), Yale University (US), NYU Langone Health (US), Investigators Research Group (United States) (US), Johns Hopkins Hospital (US)
Openalex Percentile: Top 3%
Epilepsy research and treatment
5.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.